The Affordability of Guideline-Directed Medical Therapy: Cost Sharing is a Critical Barrier to Therapy Adoption.
作者信息
Sandhu Alexander T, Heidenreich Paul A
机构信息
Division of Cardiology, Department of Medicine, Stanford University, CA (A.T.S., P.A.H.).
Medical Service, Veterans Affairs Palo Alto Health Care System, CA (P.A.H.).
出版信息
Circulation. 2021 Mar 16;143(11):1073-1075. doi: 10.1161/CIRCULATIONAHA.120.053291. Epub 2021 Mar 15.
Abstract
摘要
相似文献
1
The Affordability of Guideline-Directed Medical Therapy: Cost Sharing is a Critical Barrier to Therapy Adoption.
Circulation. 2021 Mar 16;143(11):1073-1075. doi: 10.1161/CIRCULATIONAHA.120.053291. Epub 2021 Mar 15.
2
Cost Sharing, Health Care Expenditures, and Utilization: An International Comparison.
Int J Health Serv. 2016;46(1):106-23. doi: 10.1177/0020731415615312. Epub 2015 Nov 6.
3
Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
Health Aff (Millwood). 2014 Oct;33(10):1761-9. doi: 10.1377/hlthaff.2014.0497.
4
Power of 1 Malaysian Ringgit: A Low-Cost Prescription Cost-Sharing Model in Malaysia.
Value Health Reg Issues. 2020 May;21:245-251. doi: 10.1016/j.vhri.2019.12.002. Epub 2020 Apr 27.
5
The impact of pharmaceutical rebates on patients' drug expenditures.
CMAJ. 2019 Mar 18;191(11):E308-E312. doi: 10.1503/cmaj.181041.
6
Physician and Patient Adjustment to Reference Pricing for Drugs.
JAMA Netw Open. 2020 Feb 5;3(2):e1920544. doi: 10.1001/jamanetworkopen.2019.20544.
7
Systematic review of benefit designs with differential cost sharing for prescription drugs.
Am J Manag Care. 2015 May 1;21(5):e338-48.
8
Australia's pharmaceutical cost sharing policy: reducing waste or affordability?
Aust Health Rev. 2009 May;33(2):231-40. doi: 10.1071/ah090231.
9
The cost of admission--tiered copayments for hospital use.
N Engl J Med. 2004 Jun 17;350(25):2539-42. doi: 10.1056/NEJMp048107.
10
Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability.
Aust Health Rev. 2011 Feb;35(1):37-44. doi: 10.1071/AH10902.
引用本文的文献
1
From Metabolic Syndrome to Cardiovascular-Kidney-Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction.
Anatol J Cardiol. 2025 Aug;29(8):384-393. doi: 10.14744/AnatolJCardiol.2025.5602.
2
Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care.
JAMA Cardiol. 2025 Jul 9. doi: 10.1001/jamacardio.2025.2145.
3
Challenges Related to Out-of-Pocket Costs in Heart Failure Management.
Circ Heart Fail. 2025 Mar;18(3):e011584. doi: 10.1161/CIRCHEARTFAILURE.124.011584. Epub 2025 Feb 28.
4
Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure.
Circ Heart Fail. 2025 Jan;18(1):e012357. doi: 10.1161/CIRCHEARTFAILURE.124.012357. Epub 2024 Nov 11.
5
Health insurance and clinical outcomes in patients with chronic heart failure in Latin America: an observational study of the Colombian Heart Failure Registry (RECOLFACA).
Heart Vessels. 2024 Dec;39(12):1068-1078. doi: 10.1007/s00380-024-02456-9. Epub 2024 Sep 12.
6
Medical Management and Device-Based Therapies in Chronic Heart Failure.
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101206. doi: 10.1016/j.jscai.2023.101206. eCollection 2023 Nov-Dec.
7
The economics of heart failure care.
Prog Cardiovasc Dis. 2024 Jan-Feb;82:90-101. doi: 10.1016/j.pcad.2024.01.010. Epub 2024 Jan 18.
8
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.
Curr Atheroscler Rep. 2023 Dec;25(12):1113-1127. doi: 10.1007/s11883-023-01180-5. Epub 2023 Dec 18.
9
Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.
J Am Coll Cardiol. 2023 May 23;81(20):2043-2055. doi: 10.1016/j.jacc.2023.03.402.
10
Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.
J Am Coll Cardiol. 2023 Apr 18;81(15):1491-1501. doi: 10.1016/j.jacc.2023.02.002. Epub 2023 Feb 20.
本文引用的文献
1
Eliminating medication copayments reduces disparities in cardiovascular care.
Health Aff (Millwood). 2014 May;33(5):863-70. doi: 10.1377/hlthaff.2013.0654.
2
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
JAMA. 2007 Jul 4;298(1):61-9. doi: 10.1001/jama.298.1.61.
Zotero 插件